European Union - English - EMA (European Medicines Agency)

smithkline beecham ltd - rosiglitazone, glimepiride - diabetes mellitus, type 2 - drugs used in diabetes - avaglim is indicated in the treatment of type 2 diabetes mellitus patients who are unable to achieve sufficient glycaemic control on optimal dosage of sulphonylurea monotherapy, and for whom metformin is inappropriate because of contraindication or intolerance.

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - glimepiride - tablet, film coated - 1mg

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - glimepiride - tablet, film coated - 2mg

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - glimepiride - tablet, film coated - 4mg

Canada - English - Health Canada

glaxosmithkline inc - rosiglitazone (rosiglitazone maleate); glimepiride - tablet - 4mg; 1mg - rosiglitazone (rosiglitazone maleate) 4mg; glimepiride 1mg - sulfonylureas

Canada - English - Health Canada

glaxosmithkline inc - rosiglitazone (rosiglitazone maleate); glimepiride - tablet - 4mg; 2mg - rosiglitazone (rosiglitazone maleate) 4mg; glimepiride 2mg - sulfonylureas

Canada - English - Health Canada

glaxosmithkline inc - rosiglitazone (rosiglitazone maleate); glimepiride - tablet - 4mg; 4mg - rosiglitazone (rosiglitazone maleate) 4mg; glimepiride 4mg - sulfonylureas

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

smiithkline beecham - glimepiride, rosiglitazone maleate - film-coated tablet - 4,1 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

smiithkline beecham - glimepiride, rosiglitazone maleate - film-coated tablet - 4,2 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

smiithkline beecham - glimepiride, rosiglitazone maleate - film-coated tablet - 4,4 mg